Pulike Biological Engineering, Inc. (SHA:603566)
China · Delayed Price · Currency is CNY 10.45
-0.10 (-0.95%)
Sep 2, 2026, 2:19 PM CST
SHA:603566 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 85.51 | 137.31 | 205.26 | 317.21 | 281.65 | 168.83 |
Trading Asset Securities | 649.26 | 635.85 | 480.33 | 407.58 | 691.36 | 75 |
Cash & Short-Term Investments | 734.77 | 773.16 | 685.59 | 724.79 | 973.01 | 243.83 |
Cash Growth | 1.37% | 12.77% | -5.41% | -25.51% | 299.05% | -53.03% |
Accounts Receivable | 402.3 | 359.81 | 372.9 | 464.48 | 496.32 | 304.54 |
Other Receivables | 8.91 | 7.03 | 6.13 | 6.19 | 5.12 | 4.34 |
Receivables | 411.21 | 366.85 | 379.04 | 470.66 | 501.44 | 308.89 |
Inventory | 240.54 | 219.73 | 192.6 | 183.62 | 191.51 | 170.56 |
Other Current Assets | 17.46 | 7.57 | 10.33 | 30.4 | 17.22 | 10.15 |
Total Current Assets | 1,404 | 1,367 | 1,268 | 1,409 | 1,683 | 733.43 |
Property, Plant & Equipment | 1,192 | 1,292 | 1,163 | 1,175 | 949.86 | 651.6 |
Long-Term Investments | 132.6 | 158.64 | 304.63 | 315.51 | 356.68 | 391.95 |
Goodwill | 29.29 | 29.29 | 17.81 | 17.81 | 17.81 | 17.81 |
Other Intangible Assets | 302.64 | 303.54 | 279.18 | 283.35 | 286.47 | 276.08 |
Long-Term Deferred Tax Assets | 7.92 | 7.89 | 8.75 | 7.82 | 25.16 | 5.91 |
Long-Term Deferred Charges | - | 0.01 | 0.58 | 1.15 | 1.55 | - |
Other Long-Term Assets | 72.78 | 78.31 | 56.14 | 51.85 | 74.82 | 91.5 |
Total Assets | 3,141 | 3,237 | 3,097 | 3,262 | 3,396 | 2,168 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 133.37 | 135.81 | 128.63 | 144.94 | 170.71 | 48.95 |
Accrued Expenses | 39.24 | 187.58 | 227.63 | 264.73 | 290.75 | 207.56 |
Short-Term Debt | - | - | - | - | 7.01 | - |
Current Portion of Leases | - | 6.95 | 1.08 | 1 | 0.81 | - |
Current Income Taxes Payable | 10.62 | 1.64 | 0.74 | 5.2 | 16.02 | 6.88 |
Current Unearned Revenue | 54.74 | 54.73 | 33.41 | 23.73 | 12.56 | 15.16 |
Other Current Liabilities | 161.04 | 38.44 | 42.44 | 68.43 | 58.28 | 67.05 |
Total Current Liabilities | 406.22 | 425.14 | 433.93 | 508.03 | 556.13 | 345.59 |
Long-Term Debt | 18.45 | 18.82 | - | - | - | - |
Long-Term Leases | 0.35 | 1.47 | 0.17 | 1.06 | 1.87 | - |
Long-Term Unearned Revenue | 28.57 | 34.02 | 31.38 | 21.6 | 8.26 | 6.97 |
Long-Term Deferred Tax Liabilities | 23.85 | 20.55 | 5.62 | 7.65 | 25.29 | 15.27 |
Total Liabilities | 477.45 | 500 | 471.11 | 538.33 | 591.56 | 367.83 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 346.06 | 346.06 | 346.06 | 352.92 | 352.92 | 321.5 |
Additional Paid-In Capital | 1,197 | 1,197 | 1,197 | 1,324 | 1,346 | 473.21 |
Retained Earnings | 1,064 | 1,123 | 1,143 | 1,188 | 1,239 | 1,139 |
Treasury Stock | -60.34 | -60.34 | -60.34 | -141.19 | -133.55 | -133.55 |
Total Common Equity | 2,546 | 2,606 | 2,626 | 2,724 | 2,804 | 1,800 |
Minority Interest | 117.47 | 130.92 | - | - | - | - |
Shareholders' Equity | 2,664 | 2,737 | 2,626 | 2,724 | 2,804 | 1,800 |
Total Liabilities & Equity | 3,141 | 3,237 | 3,097 | 3,262 | 3,396 | 2,168 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 26.01 | 27.23 | 1.26 | 2.05 | 9.69 | - |
Net Cash (Debt) | 708.76 | 745.92 | 684.33 | 722.74 | 963.32 | 243.83 |
Net Cash Growth | -2.05% | 9.00% | -5.31% | -24.97% | 295.08% | -53.03% |
Net Cash Per Share | 2.09 | 2.18 | 1.99 | 2.07 | 2.98 | 0.78 |
Filing Date Shares Outstanding | 332.93 | 341.92 | 341.92 | 344.61 | 346.06 | 314.64 |
Total Common Shares Outstanding | 332.93 | 341.92 | 341.92 | 345.7 | 346.06 | 314.64 |
Working Capital | 997.76 | 942.17 | 833.64 | 901.45 | 1,127 | 387.84 |
Book Value Per Share | 7.65 | 7.62 | 7.68 | 7.88 | 8.10 | 5.72 |
Tangible Book Value | 2,215 | 2,273 | 2,329 | 2,423 | 2,500 | 1,507 |
Tangible Book Value Per Share | 6.65 | 6.65 | 6.81 | 7.01 | 7.22 | 4.79 |
Buildings | - | 1,021 | 954.69 | 599.48 | 486.01 | 370.61 |
Machinery | - | 966.41 | 700.97 | 634.4 | 525.17 | 397.97 |
Construction In Progress | - | 23.17 | 9.3 | 382.75 | 308.86 | 205.54 |